Centers for Disease Control and Prevention,National Center for HIV Viral Hepatitis STD and TB Prevention

This poster states that hepatitis B is a serious disease spread by sexual contact. It promotes vaccination as a way of preventing the disease.

This poster states that 1 in 12 Asian has chronic Hepatitis B and advises Asian Americans to consult their doctors about getting tested.

This poster explains that hepatitis can be transmitted through sex with an infected person and that men who have sex with men are at increased risk for hepatitis A and B. It promotes hepatitis prevention through vaccines.

This report examines existing sexually transmitted disease (STD) screening programs in large jails to learn lessons that can benefit other health departments that want to establish or expand chlamydia (CT) and gonorrhea (GC) screening programs in their local jails. It provides key findings and recommendations for implementing and/or expanding jail STD screening programs. The appendices give summaries of each jail vist and contact information is also provided from each jail visit.

This report summarizes trends in cephalosporin susceptibility among N. gonorrhoeae isolates in the United States during 2000--2010 using data from the Gonococcal Isolate Surveillance Project (GISP). During that period, the percentage of isolates with elevated minimum inhibitory concentrations (MICs) to cephalosporins (=0.25 µg/mL for cefixime and =0.125 µg/mL for ceftriaxone) increased from 0.2% in 2000 to 1.4% in 2010 for cefixime and from 0.1% in 2000 to 0.3% in 2010 for ceftriaxone.

On October 25, 2011, the Advisory Committee on Immunization Practices (ACIP) recommended routine use of quadrivalent human papillomavirus (HPV) vaccine (HPV4; Gardasil, Merck & Co. Inc.) in males aged 11 or 12 years. ACIP also recommended vaccination with HPV4 for males aged 13 through 21 years who have not been vaccinated previously or who have not completed the 3-dose series; males aged 22 through 26 years may be vaccinated. These recommendations replace the October 2009 ACIP guidance that HPV4 may be given to males aged 9 through 26 years.

This Toolkit is the principal outcome of the second phase of the EPT law project. It is intended as a resource for voluntary use by government officials at the state and local levels, their public and private sector partners, and others who are interested in adopting or facilitating the implementation of statutes or regulations that permit EPT in clinical practice. This Toolkit is not designed to provide specific legal guidance or advice and does not represent the official legal positions of federal, state, or local governments.

This visual file is a set of 30 slides providing information on the epidemiology of HIV infection through 2009.

In this report, the CDC used the National HIV Surveillance System data to estimate among youths, prevalence rates of diagnosed HIV infection in 2009 and the number of new infections in 2010. CDC used the 2009 and 2010 Youth Risk Behavior Surveillance System for 9th -12th grade students and the 2010 National Health Interview Survey for persons 18-24 years. Prevalence of diagnosed HIV was 69.5 per 100,000 youths at the end of 2009. Youth accounted for 12,200 (25.7 percent) new HIV infections in 2010.

This slide set presents surveillance data on children younger than age 13 years with HIV in the United States.